Tech Company Financing Transactions
MiLaboratories Funding Round
K Fund, Acrobator Ventures and Courtyard Ventures participated in a Series A funding round for MiLaboratories. The funding round was announced on 10/10/2024.
Transaction Overview
Company Name
Announced On
10/10/2024
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds for hire talent and expand into new markets, with a strategic emphasis on the United States.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
2261 Market St
San Francisco, CA 94114
USA
San Francisco, CA 94114
USA
Phone
Website
Email Address
Overview
MiXCR is an ultimate software platform for analysis of Next-Generation Sequencing (NGS) data for immune profiling. It's widely used to empower R&D in vaccine development, CAR-T therapies, antibody discovery and other areas. 8 out of 10 Big Pharma companies choose MiXCR for studying immune system. Aiming to support non-profit research, we provide MiXCR for free for academic and non-commercial use. For years, MiXCR is being the number one solution for immune system studies in academia and industry.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stan Poslavsky
Browse more venture capital transactions:
Prev: 10/10/2024: In Bold Print venture capital transaction
Next: 10/10/2024: Aperture Data venture capital transaction
Share this article
News on VC Transactions
We do our best to document funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs